← Leaderboards
Catherine Lozupone
University Of Colorado
$9,964,999
Attributed
$16,387,823
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,387,823 · 9
By mechanism
R01$9,708,580 · 4
U01$3,880,251 · 1
P30$1,661,295 · 2
K01$737,867 · 1
R21$399,830 · 1
Top collaborators
- Brent E Palmer19 shared
- Thomas B. Campbell9 shared
- Sean P Colgan4 shared
- Laurent Gapin2 shared
- Martin Mccarter2 shared
- Theresa M Medina2 shared
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaMicrobiomeDietMicrobialCellsMetabolicFecesMicrobeGut MicrobiotaLinkSamplingImmuneLeadGut MicrobiomeIntestinesGnotobioticAutomobile DrivingIn VitroProductionPhenotypeHiv SeropositivityMicrobiotaMucous MembraneGrant
Grant awards (37)
Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection$775,185
U01 · FY2025 · AI · contact PI
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$690,739
R01 · FY2025 · DK · contact PI
Core 2 - Mucosal Immunobiology Core (MIC)$218,003
P30 · FY2025 · AR · contact PI
Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection$775,395
U01 · FY2024 · AI · contact PI
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$663,109
R01 · FY2024 · DK · contact PI
Core 2 - Mucosal Immunobiology Core (MIC)$348,933
P30 · FY2024 · AR · contact PI
Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection$777,060
U01 · FY2023 · AI · contact PI
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$690,739
R01 · FY2023 · DK · contact PI
Core 2 - Mucosal Immunobiology Core (MIC)$356,819
P30 · FY2023 · AR · contact PI
Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection$776,282
U01 · FY2022 · AI · contact PI
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$690,739
R01 · FY2022 · DK · contact PI
Core 2 - Mucosal Immunobiology Core (MIC)$364,340
P30 · FY2022 · AR · contact PI
Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection$776,329
U01 · FY2021 · AI · contact PI
Core 2 - Mucosal Immunobiology Core (MIC)$373,200
P30 · FY2021 · AR · contact PI
Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome$218,089
R21 · FY2021 · CA
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2020 · HL
Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome$181,741
R21 · FY2020 · CA
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$600,187
R01 · FY2019 · DK
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2019 · HL
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$600,188
R01 · FY2018 · DK
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2018 · HL
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2018 · DK · contact PI
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$599,064
R01 · FY2017 · DK
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2017 · HL
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2017 · DK · contact PI
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$599,063
R01 · FY2016 · DK
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2016 · DK · contact PI
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$600,187
R01 · FY2015 · DK
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2015 · DK · contact PI
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$153,901
R01 · FY2015 · DK · contact PI
The Role of Syntrophic Bacteria in Methanogenic Metabolism in the Human Gut$135,051
K01 · FY2015 · DK · contact PI
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$387,708
R01 · FY2014 · DK · contact PI
The Role of Syntrophic Bacteria in Methanogenic Metabolism in the Human Gut$150,564
K01 · FY2014 · DK · contact PI
The Role of Syntrophic Bacteria in Methanogenic Metabolism in the Human Gut$117,545
K01 · FY2013 · DK · contact PI
The Role of Syntrophic Bacteria in Methanogenic Metabolism in the Human Gut$32,459
K01 · FY2013 · DK · contact PI
The Role of Syntrophic Bacteria in Methanogenic Metabolism in the Human Gut$151,124
K01 · FY2012 · DK · contact PI
The Role of Syntrophic Bacteria in Methanogenic Metabolism in the Human Gut$151,124
K01 · FY2011 · DK · contact PI